Oxolipidomics profile in major depressive disorder: Comparing remitters and non-remitters to repetitive transcranial magnetic stimulation treatment

BACKGROUND: Repetitive Transcranial Magnetic Stimulation [rTMS] is increasingly being used to treat Major Depressive Disorder [MDD]. Given that not all patients respond to rTMS, it would be clinically useful to have reliable biomarkers that predict treatment response. Oxidized phosphatidylcholine [O...

Descripción completa

Detalles Bibliográficos
Autores principales: Stirton, Hannah, Meek, Benjamin P., Edel, Andrea L., Solati, Zahra, Surendran, Arun, Aukema, Harold, Modirrousta, Mandana, Ravandi, Amir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7877633/
https://www.ncbi.nlm.nih.gov/pubmed/33571313
http://dx.doi.org/10.1371/journal.pone.0246592

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7877633/
https://www.ncbi.nlm.nih.gov/pubmed/33571313
http://dx.doi.org/10.1371/journal.pone.0246592

Ejemplares similares